Société RLS Global AB (publ) Nasdaq Stockholm
Actions
SE0005190725
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Director of Finance/CFO | 64 | 22/08/23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01/01/21 |
Susanne Olausson
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/08/12 | |
Director/Board Member | 63 | 01/08/17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01/01/23 |
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Lars Johansson
CHM | Chairman | 58 | 01/01/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 79 874 705 | 41 780 367 ( 52,31 %) | 0 | 52,31 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+30,38% | 684 Md | |
+26,51% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+16,70% | 240 Md | |
+8,78% | 208 Md | |
-7,93% | 200 Md | |
+7,68% | 166 Md |